Diabetes Mellitus after COVID-19 Vaccination in a Patient with Impaired Glucose Metabolism: Case Report
Open Access
- 11 September 2023
- journal article
- research article
- Published by SCEEMP in Safety and Risk of Pharmacotherapy
- Vol. 12 (1) , 58-67
Abstract
SCIENTIFIC RELEVANCE. The clinical features of COVID-19 in patients with comorbidities, including diabetes mellitus (DM), have already been discussed in the medical literature. However, the available data on blood glucose levels in patients with DM during SARS-CoV-2 infection and after COVID-19 vaccination are clearly insufficient to estimate the importance of the changes taking place.AIM. The study aimed to show that patients with DM or impaired glucose metabolism need glycaemic monitoring during COVID-19 disease and after COVID-19 vaccination, drawing on the example of a clinical case.MATERIALS AND METHODS. The study analysed the medical records of a 58-year-old male patient newly diagnosed with DM. He received inpatient and outpatient treatment after COVID-19 vaccination and SARS-CoV-2 infection in February–November 2021. In 2014, the patient was diagnosed with impaired glucose metabolism, including fasting hyperglycaemia (≤ 9 mmol/L), which was corrected by diet.RESULTS. After vaccination with Gam-COVID-Vac component 1 in February 2021, the patient developed polydipsia, polyuria, and arterial hypertension. His laboratory findings were as follows: blood glucose, 25 mmol/L; glycated haemoglobin, 10.7%; fasting insulin, 28.4 μIU/mL; calcium, 2.45 mmol/L; and 25-hydroxyvitamin D, 21 ng/mL. The patient was diagnosed with new-onset type 2 DM, admitted to the endocrinology department of a multidisciplinary hospital, and discharged when his condition stabilised after 14 days of treatment. After vaccination with Gam-COVID-Vac component 2, the patient’s glucose levels did not change. In November 2021, the patient was diagnosed with SARS-CoV-2 infection. Even though all symptoms had resolved within 3 days, the virus persisted in the blood for 12 days without clinical manifestations of the disease. This was confirmed by repeated polymerase chain reaction testing. The patient had moderate hyperglycaemia despite antidiabetic treatment; his glucose levels were restored to normal without hospitalisation.CONCLUSIONS. Timely vaccination against COVID-19 in patients with DM, hypertension, and obesity contributes to a mild course of COVID-19 and helps avoid complications in the lungs and other organs. For patients with DM or glucose metabolism disorders, blood glucose monitoring is advisable for detecting and correcting possible hyperglycaemia after vaccination and/or recovery from COVID-19.Keywords
This publication has 36 references indexed in Scilit:
- High Prevalent Hypovitaminosis D Is Associated with Dysregulation of Calcium-parathyroid Hormone-vitamin D Axis in Patients with Chronic Liver DiseasesJournal of Clinical and Translational Hepatology, 2018
- mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3Proceedings of the National Academy of Sciences, 2018
- Plasma levels of the proprotein convertase furin and incidence of diabetes and mortalityJournal of Internal Medicine, 2018
- mTOR: A double-edged sword for diabetesJournal of Leukocyte Biology, 2018
- Characterization of ACE and ACE2 Expression within Different Organs of the NOD MouseInternational Journal of Molecular Sciences, 2017
- Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes RatsEndocrinology, 2015
- Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with CirrhosisPLOS ONE, 2015
- Pioglitazone Upregulates Angiotensin Converting Enzyme 2 Expression in Insulin-Sensitive Tissues in Rats with High-Fat Diet-Induced Nonalcoholic SteatohepatitisThe Scientific World Journal, 2014
- Prevalence of Vitamin D Deficiency in Chronic Liver DiseaseDigestive Diseases and Sciences, 2009
- Binding of SARS coronavirus to its receptor damages islets and causes acute diabetesActa Diabetologica, 2009